You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海峽創新(300300.SZ):擬以0元收購好醫友互聯網醫院(平潭)40%股權
格隆匯 07-22 19:31

格隆匯7月22日丨海峽創新(300300.SZ)公佈,2021722日,公司召開第四屆董事會第五次會議,4票同意,0反對,0票棄權的表決結果審議通過了《關於收購好醫友互聯網醫院(平潭)有限公司股權暨關聯交易的議案》,關聯董事曹陽、林向陽、謝家清、倪晨勛、李童童對該議案進行了迴避表決,同意公司收購好醫友所持有但未實繳的合資公司好醫友互聯網醫院(平潭)有限公司40%股權(對應1200萬元出資額),交易價格為0元。收購完成後,公司實際持有合資公司80%股權。

合資公司於20203月設立,20211月取得互聯網醫院執業許可證,是福建省第二家由第三方獨立申辦的互聯網醫院,作為公司智慧醫療實施的重要戰略平台,下一步公司將充分發揮平潭對台的特殊政策優勢,戰略重點將在中美醫療合作更突出市場化的前提下,基於台灣地區在醫療服務水平的領先優勢,合資公司將以台灣醫院、以色列特拉維夫醫療中心等新增資源來提升海峽創新智慧醫療板塊專業性壁壘。

此次收購主要目的是重新整合海峽創新智慧醫療板塊資源,集中平潭區位優勢及政策紅利,拓寬智慧醫療板塊的業務邊界。同時,收購完成後,智慧醫療板塊將形成“一核心,多衞星”的生態醫療體系,以互聯網醫院為數字醫療服務平台為基礎,中國台灣、以色列、美國等多地特色性醫療產品及服務可在慢病管理、養老康復等大健康領域精準地服務大陸台胞、福建乃至全國人民,提升平台影響力。此次公司收購好醫友持有的合資公司40%股權後擁有對其的絕對控股權,可以更好地促進合資公司的經營發展,最大限度匹配公司戰略發展方向。此次交易不會導致合併報表範圍的變更,預計不會對公司財務及經營狀況產生不利影響,不會影響公司的獨立性,亦不存在損害全體股東尤其是中小股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account